SHANGHAI: China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday. The State Medical Insurance Administration said ...
- Kimberly-Clark weighs sale of European tissues business: sources
- Blackstone seeks to boost assets with new fundraising ‘super cycle’
- Trump ‘not happy’ with Fed interest rates
- MOM Minister confuses, conceals failure of CPF scheme
- Trump rejects Putin offer on interviewing Americans
- Poundworld to close all stores costing thousands of jobs
- Sky targeted by hostile fans on L’Alpe d’Huez climb